Details:
BAT2022 demonstrated potent in vivo efficacy against SARS-CoV-2 in a mice model both prophylactically and therapeutically, protecting animals from disease progress and abolishing virus replication in the lungs.
Lead Product(s): 2F8,VHH18. 2F8
Therapeutic Area: Infections and Infectious Diseases Product Name: BAT2022
Highest Development Status: Discovery Product Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 11, 2021
Details:
HitGen will apply its platform technology, based on the design, synthesis and screening of DNA-encoded libraries (DEL) to identify small molecule leads against targets of interest to Evotec SE in the field of anti-infectives.
Lead Product(s): Undisclosed
Therapeutic Area: Infections and Infectious Diseases Product Name: Undisclosed
Highest Development Status: Discovery Product Type: Small molecule
Partner/Sponsor/Collaborator: Evotec
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration June 08, 2020